Loading…
Evonik reported second-quarter adjusted EBITDA of €450 million, down 38 percent year over year, with group sales down 19 percent. Volumes fell 9 percent and prices fell 5 percent.
The company said weak demand in Germany, Europe and China prevented a turnaround.
Weak industrial demand and falling prices at a major methionine producer signal soft amino acid pricing and limited near-term demand for feed-grade methionine.
evonik.comJörg Wagner, Richard WeissAug 10, 2023Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
